|
🐜
|
Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: a TransATAC study.
14 auth.
M. Dowsett,
J. Cuzick,
C. Wale,
J. Forbes,
E. Mallon,
J. Salter,
E. Quinn,
A. Dunbier,
M. Baum,
A. Buzdar,
...
A. Howell,
R. Bugarini,
F. Baehner,
S. Shak
|
9 |
2010 |
9
🐜
|
|
🐜
|
Comparison of PAM50 risk of recurrence score with oncotype DX and IHC4 for predicting risk of distant recurrence after endocrine therapy.
10 auth.
M. Dowsett,
I. Šestak,
E. López-Knowles,
K. Sidhu,
A. Dunbier,
J. Cowens,
...
S. Ferree,
J. Storhoff,
C. Schaper,
J. Cuzick
|
9 |
2013 |
9
🐜
|
|
🐜
|
Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer
12 auth.
W. Grady,
J. Willis,
P. Guilford,
A. Dunbier,
T. Toro,
H. Lynch,
...
G. Wiesner,
Kelly Ferguson,
C. Eng,
Jae‐Gahb Park,
Seong-Jin Kim,
S. Markowitz
|
8 |
2000 |
8
🐜
|
|
🐜
|
Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population.
12 auth.
D. Sgroi,
I. Šestak,
J. Cuzick,
Yi Zhang,
C. Schnabel,
B. Schroeder,
...
M. Erlander,
A. Dunbier,
Kally Sidhu,
E. López-Knowles,
P. Goss,
M. Dowsett
|
8 |
2013 |
8
🐜
|
|
🐜
|
ERα-dependent E2F transcription can mediate resistance to estrogen deprivation in human breast cancer.
19 auth.
T. Miller,
J. Balko,
Emily M. Fox,
Z. Ghazoui,
A. Dunbier,
H. Anderson,
M. Dowsett,
Aixiang Jiang,
R. A. Smith,
S. Maira,
...
H. Manning,
A. González-Angulo,
G. Mills,
C. Higham,
S. Chanthaphaychith,
M. Kuba,
W. Miller,
Y. Shyr,
C. Arteaga
|
7 |
2011 |
7
🐜
|
|
🐢
|
Emerging Biomarkers and New Understanding of Traditional Markers in Personalized Therapy for Breast Cancer
M. Dowsett,
A. Dunbier
|
7 |
2008 |
7
🐢
|
|
🐜
|
Destabilized adhesion in the gastric proliferative zone and c-Src kinase activation mark the development of early diffuse gastric cancer.
11 auth.
B. Humar,
R. Fukuzawa,
Vanessa R Blair,
A. Dunbier,
H. More,
A. Charlton,
...
Han-Kwang Yang,
W. Kim,
A. Reeve,
I. Martin,
P. Guilford
|
7 |
2007 |
7
🐜
|
|
🦁
|
Molecular Profiling of Aromatase Inhibitor–Treated Postmenopausal Breast Tumors Identifies Immune-Related Correlates of Resistance
10 auth.
A. Dunbier,
Z. Ghazoui,
H. Anderson,
J. Salter,
A. Nerurkar,
P. Osin,
...
R. A’Hern,
W. Miller,
I. Smith,
M. Dowsett
|
6 |
2013 |
6
🦁
|
|
🦁
|
Relationship between plasma estradiol levels and estrogen-responsive gene expression in estrogen receptor-positive breast cancer in postmenopausal women.
14 auth.
A. Dunbier,
H. Anderson,
Z. Ghazoui,
E. Folkerd,
R. A’Hern,
R. Crowder,
J. Hoog,
I. Smith,
P. Osin,
A. Nerurkar,
...
J. Parker,
C. Perou,
M. Ellis,
M. Dowsett
|
6 |
2010 |
6
🦁
|
|
🐜
|
Accurate Prediction and Validation of Response to Endocrine Therapy in Breast Cancer.
10 auth.
A. Turnbull,
Laura M. Arthur,
L. Renshaw,
A. Larionov,
C. Kay,
A. Dunbier,
...
J. Thomas,
M. Dowsett,
A. Sims,
J. Dixon
|
6 |
2015 |
6
🐜
|
|
🐜
|
A Gene Expression Signature from Human Breast Cancer Cells with Acquired Hormone Independence Identifies MYC as a Mediator of Antiestrogen Resistance
12 auth.
T. Miller,
J. Balko,
Z. Ghazoui,
A. Dunbier,
H. Anderson,
M. Dowsett,
...
A. González-Angulo,
G. Mills,
W. Miller,
Huiyun Wu,
Y. Shyr,
C. Arteaga
|
6 |
2011 |
6
🐜
|
